Literature DB >> 2048534

Intraperitoneal contrast material improves the CT detection of peritoneal metastases.

R A Halvorsen1, C Panushka, G J Oakley, J G Letourneau, L L Adcock.   

Abstract

The preoperative detection of peritoneal metastases from gynecologic malignancies is difficult; in particular, CT often fails to detect peritoneal implants. This study was designed to determine if the administration of intraperitoneal iodinated contrast media would increase the CT detection of such peritoneal metastases. Prospectively, both standard and intraperitoneal contrast-enhanced CT studies of the abdomen and pelvis were performed in 16 patients with suspected gynecologic tumors. All patients then underwent operative staging, with the location and number of metastases documented. The intraperitoneal enhanced CT studies were more sensitive in the detection of peritoneal metastases than standard CT examinations. Whereas routine CT detected peritoneal metastases in seven (64%) of 11 patients with surgically proved implants, the intraperitoneal enhanced CT studies detected peritoneal metastases in all 11 patients. Depending on the specific intraperitoneal compartments involved, the sensitivity of intraperitoneal enhanced CT in the detection of peritoneal metastases was two- to fourfold greater than that of standard CT examinations. Our results suggest that intraperitoneal enhanced CT is superior to standard CT in the detection of peritoneal metastases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2048534     DOI: 10.2214/ajr.157.1.2048534

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer.

Authors:  S H Chandrashekhara; S Thulkar; D N Srivastava; L Kumar; R Hariprasad; S Kumar; M C Sharma
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

2.  Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis.

Authors:  Carolin D Duhr; Werner Kenn; Ralph Kickuth; Alexander G Kerscher; Christoph-Thomas Germer; Dietbert Hahn; Joerg O W Pelz
Journal:  World J Surg Oncol       Date:  2011-12-21       Impact factor: 2.754

3.  Induced pneumoperitoneum in CT evaluation of peritoneal carcinomatosis.

Authors:  F Caseiro-Alves; M Gonçalo; E Abraul; E Pinto; C Oliveira; V Ramos
Journal:  Abdom Imaging       Date:  1995 Jan-Feb

Review 4.  The different faces of metastatic melanoma in the gastrointestinal tract.

Authors:  Eva Mendes Serrao; Ana Maria Costa; Sergio Ferreira; Victoria McMorran; Emma Cargill; Caroline Hough; Ashley S Shaw; Brent O'Carrigan; Christine A Parkinson; Pippa G Corrie; Timothy J Sadler
Journal:  Insights Imaging       Date:  2022-10-04

5.  Sonographic detection of peritoneal carcinomatosis: a prospective study of 37 cases.

Authors:  M Rioux; C Michaud
Journal:  Abdom Imaging       Date:  1995 Jan-Feb

Review 6.  CT and MRI of ovarian cancer.

Authors:  R Forstner; H Hricak; S White
Journal:  Abdom Imaging       Date:  1995 Jan-Feb

7.  Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound.

Authors:  T G John; J D Greig; J L Crosbie; W F Miles; O J Garden
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

8.  Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer.

Authors:  Murtuza Rampurwala; Murali K Ravoori; Wei Wei; Valen E Johnson; Raghunandan Vikram; Vikas Kundra
Journal:  Transl Oncol       Date:  2009-05       Impact factor: 4.243

9.  Ovarian dysgerminoma in two sisters.

Authors:  Bander F Aldhafery
Journal:  J Family Community Med       Date:  2008-09

Review 10.  Blind spots at oncological CT: lessons learned from PET/CT.

Authors:  Jacob Sosna; Steven J Esses; Nikolay Yeframov; Hanna Bernstine; Tamar Sella; Shifra Fraifeld; Jonathan B Kruskal; David Groshar
Journal:  Cancer Imaging       Date:  2012-08-10       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.